Avacta Group (AVCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
04 Nov 2009 07:00 AM
PRN
Notice of Results
21 Oct 2009 07:00 AM
PRN
Placing and Issue of Equity
06 Oct 2009 07:00 AM
RNS
Optim - Second Order
28 Sep 2009 07:00 AM
PRN
Re Agreement
16 Sep 2009 03:03 PM
RNS
Holding(s) in Company
11 Sep 2009 04:26 PM
RNS
Holding(s) in Company
11 Sep 2009 03:59 PM
RNS
Holding(s) in Company
07 Aug 2009 07:00 AM
PRN
Pre-Close Trading Statement
28 Jul 2009 05:07 PM
RNS
Holding(s) in Company
13 Jul 2009 04:40 PM
RNS
Director/PDMR Shareholding
10 Jul 2009 04:17 PM
RNS
Issue of Equity
09 Jul 2009 04:29 PM
RNS
Further re Acquisition of The
23 Apr 2009 07:00 AM
RNS
Half Yearly Report
23 Apr 2009 07:00 AM
PRN
OPTIM Product Launch
31 Mar 2009 12:20 PM
PRN
Analyst Presentation
30 Mar 2009 12:59 PM
PRN
Director/PDMR Shareholding
03 Mar 2009 01:17 PM
RNS
Completion of Acquisition of
12 Feb 2009 01:23 PM
RNS
Rule 8.1- (Curidium Medica Pl
09 Feb 2009 12:39 PM
RNS
Result of EGM
09 Feb 2009 07:00 AM
PRN
Acquisition
26 Jan 2009 07:00 AM
PRN
Result of AGM
15 Jan 2009 09:24 AM
PRN
Acquisition of Theragenetics Limited
09 Jan 2009 07:00 AM
PRN
Acquisition(s)
08 Jan 2009 02:29 PM
RNS
Director/PDMR Shareholding
07 Jan 2009 07:00 AM
RNS
Issue of Equity
12 Dec 2008 12:06 PM
RNS
Final Results
20 Nov 2008 04:14 PM
RNS
Director/PDMR Shareholding
05 Nov 2008 12:42 PM
RNS
Issue of Equity
04 Nov 2008 07:00 AM
PRN
Final Results
13 Oct 2008 07:00 AM
PRN
Change of Adviser
11 Sep 2008 07:00 AM
PRN
Product Launch
21 Aug 2008 07:00 AM
PRN
Trading Statement
14 Aug 2008 11:03 AM
PRN
Product Development Partnership
28 Jul 2008 07:00 AM
PRN
Product Launch
23 Jul 2008 02:54 PM
PRN
Director/PDMR Shareholding
22 Jul 2008 04:24 PM
PRN
Director/PDMR Shareholding
11 Jul 2008 07:00 AM
PRN
Customer Agreement
14 Apr 2008 07:00 AM
PRN
Half-yearly Report
04 Apr 2008 05:20 PM
RNS
Director/PDMR Shareholding
31 Mar 2008 07:00 AM
RNS
Total Voting Rights
10 Mar 2008 03:12 PM
RNS
Issue of Equity
31 Jan 2008 11:36 AM
RNS
Total Voting Rights
07 Jan 2008 10:50 AM
PRN
Re Agreement
02 Jan 2008 05:14 PM
PRN
Issue of Equity
31 Dec 2007 07:00 AM
PRN
Total Voting Rights
14 Dec 2007 03:30 PM
PRN
Acquisition(s)
14 Dec 2007 03:05 PM
PRN
AGM Statement
21 Nov 2007 07:01 AM
RNS
Notice of AGM
14 Nov 2007 09:08 AM
PRN
Acquisition
09 Nov 2007 04:59 PM
PRN
Directorate Appointment

Avacta Group plc is a United Kingdom-based life sciences company focused on improving healthcare outcomes through targeted cancer treatments and diagnostics. The Company has two segments: Therapeutics and Diagnostics. The Therapeutics segment is a clinical stage oncology biotech division harnessing therapeutic platforms to develop novel, highly targeted cancer drugs. The Diagnostics segment is focused on supporting healthcare professionals and broadening access to diagnostics.

It has two platforms: preICISION and Affimer. The Company's preICISION platform is a highly specific substrate for fibroblast activation protein (FAP) which is upregulated in most solid tumors compared with healthy tissues. The preICISION platform harnesses this tumor specific protease to activate preICISION peptide drug conjugates and preICISION antibody/Affimer drug conjugates in the tumor microenvironment. Its lead preICISION program AVA6000, a peptide drug conjugate form of doxorubicin, is in Phase 1 studies.

Avacta Group share price launched at 5,448p in 2003. 

UK 100

Latest directors dealings